The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


DOMOSEDAN GEL 7.6 mg/ml oromucosal gel

7.6 milligram(s)/millilitre Oromucosal gel

Orion CorporationVPA10664/001/001

Main Information

Trade NameDOMOSEDAN GEL 7.6 mg/ml oromucosal gel
Active SubstancesDetomidine hydrochloride
Strength7.6 milligram(s)/millilitre
Dosage FormOromucosal gel
Licence HolderOrion Corporation
Licence NumberVPA10664/001/001

Group Information

ATC CodeQN05CM90 detomidine
Therapeutic ClassNeurological Preparations
SpeciesHorses

Status

Authorised/WithdrawnAuthorised
Licence Issued27/02/2009
Legal StatusVPO: Veterinary Practitioner Only as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back